U.S. Biotech Stock News

Investors may be wondering if Sarepta Therapeutics at around US$22.80 is starting to look interesting again, or if the risks still dominate the story. The stock has recently posted an 11.3% return over 7 days and 36.4% over 30 days, although the 1-year return sits at a 56.5% decline and the 3-year return at an 83.8% decline, with a 67.1% decline over 5 years and a 7.0% return year to date. These moves have put Sarepta back on many watchlists as investors reassess the balance between long...

With no single headline event driving attention today, WEX (WEX) is drawing interest around its recent trading performance, including a decline of about 6% over the past month and a gain of roughly 3.5% over the past three months. See our latest analysis for WEX. At the current share price of $157.10, WEX has a 1-year total shareholder return of 30.74%. However, the 30-day share price return of about 6% in declines suggests some recent momentum is fading. If WEX's recent moves have you...

Investors may be wondering if Valaris at around US$97 per share still offers value, or if most of the opportunity has already played out. The stock has pulled back by around 1% over the last week, but is still up 11.3% over 30 days, 86.8% year to date and 211.9% over the past year. This naturally raises questions about how much upside or risk is now priced in. Recent coverage has focused less on short term headlines and more on Valaris's position in the energy services space, including...

Recently, Adecoagro was highlighted by Zacks with a Rank #2 rating and an A for Value, reflecting relatively favorable earnings estimate revisions and valuation metrics versus an agriculture peer. This recognition underlines how Adecoagro’s current earnings outlook and pricing on measures such as forward P/E and PEG ratio compare attractively within its sector. We will now explore how this upgraded earnings outlook and value profile might influence Adecoagro’s existing investment narrative...

Vertex Inc. has announced advancements in their AI-powered capabilities to improve compliance processes within the Vertex Cloud platform. By integrating artificial intelligence, the platform addresses the growing complexity of regulatory demands by enhancing accuracy, accountability, and audit readiness. The AI application allows for earlier risk identification and more consistent decision-making throughout the compliance lifecycle, reducing the need for manual interventions and disruptions...

Wondering if Customers Bancorp at around US$71.70 is still offering value or if most of the upside is already priced in? This article walks through what the current share price might be implying about the business. The stock has moved 6.6% over the last week and 6.3% over the last month, while year to date it is showing a 3.8% decline and a 65.2% return over the past year, with a very large 3 year return and a 114.5% return over 5 years. Recent coverage has focused on how regional banks are...

Wondering whether Mohawk Industries at around US$96.94 is a bargain or a value trap? This article breaks down what the current share price might be implying. The stock has seen mixed returns, with a 1.7% move over the last 7 days, a 9.7% decline over 30 days, and returns of 11.5% lower year to date and 5.1% lower over the past year. The 3 year return is 2.3% and the 5 year return is 52.5% lower. Recent headlines around Mohawk Industries have focused on broader housing and renovation trends,...

Why Golar LNG Is On Investors’ Radar Today Golar LNG (GLNG) has attracted fresh attention after a strong recent run in its share price, with gains over the past month and past 3 months prompting investors to reassess the LNG-focused business. See our latest analysis for Golar LNG. That recent momentum, including a 30 day share price return of 18.42% and a 90 day share price return of 48.27%, sits alongside a very strong 1 year total shareholder return of 76.06% and a multi year track record...

Recent price performance and business snapshot ESAB (ESAB) shares last closed at US$96.11, with recent returns showing a 2.3% decline over the past day, a 5.2% gain over the past week, and weaker performance over the month and past 3 months. The company operates a global welding and cutting equipment business with US$2.84b in revenue and US$251.42m in net income, serving customers across EMEA, Asia Pacific, the United States, and the rest of the Americas. See our latest analysis for...

Merck (NYSE:MRK) is acquiring Terns Pharmaceuticals in a $6.7b deal, one of the largest biopharma M&A transactions announced so far in 2026. The transaction is centered on expanding Merck's oncology and hematology pipeline with Terns' early and mid stage cancer assets. The move aligns with Merck's effort to address upcoming patent expiries and broaden its portfolio beyond its Keytruda franchise. For investors tracking NYSE:MRK, this deal lands at a time when the stock trades around $120.85...

Lumen Technologies, Inc. has proposed amendments to its Articles of Incorporation, to be voted on at its May 20, 2026 Annual Meeting, that would remove supermajority voting requirements for director removal, certain business combinations, key charter and bylaw changes, and provisions on director liability and indemnification. This governance shift could make it easier for shareholders to influence major corporate decisions and board composition, potentially reshaping how future transactions...

Leadership change and debt offer draw attention to Williams Companies stock Williams Companies (WMB) is in focus after Executive Board Chair Alan S. Armstrong resigned from the Board to accept a United States Senate appointment, with Stephen W. Bergstrom returning as Chairman. At the same time, subsidiary Transco launched an exchange offer for US$1.7b in senior notes. This move is aimed at managing its financial structure and supporting growth initiatives that investors may want to factor...

If you are wondering whether Robinhood Markets at around US$69.78 is offering value or just headline excitement, this breakdown will help you separate story from price. The stock has had a mixed run, with a 7.1% gain over the last week, a 9.5% decline over the past month, a 39.4% drop year to date, and a 97.1% return over the last year, while the three year return is very large. Recent news coverage has focused on Robinhood's role as a major trading platform for retail investors, as well as...

In March 2026, Tapcheck Inc. announced an agreement with Paychex, Inc. to embed real-time earned wage access into the Paychex HR PEO platform, allowing eligible employees to move a portion of earned pay instantly via the Tapcheck app or a free Tapcheck Mastercard. By tightly integrating on-demand pay with existing payroll data and controls, Paychex is strengthening its financial wellness offering while giving PEO clients a low-friction tool to compete for and retain staff in complex,...

If you are looking at CenterPoint Energy and wondering whether the current share price still offers value, the key question is how that price lines up with the underlying fundamentals. The stock last closed at US$43.59, with returns of 1.4% over 7 days, flat over 30 days, 12.5% year to date, 25.6% over 1 year, 53.7% over 3 years, and 112.1% over 5 years. This gives you a wide range of recent performance to weigh up against valuation. Recent coverage has focused on how utilities like...

Covista (CVSA) shares are in focus after the company expanded Michael Betz’s role to Chief Growth & Innovation Officer, adding oversight of marketing while he continues leading Walden University and Covista’s digital organization. See our latest analysis for Covista. The leadership reshuffle comes as investors have seen a 14.9% 1 month share price return and a 12.2% year to date share price return, alongside an 18.7% 1 year total shareholder return and very large 3 year gains. This suggests...

Monolithic Power Systems (MPWR) is back in focus after robust quarterly results, upbeat revenue guidance and a higher cash dividend, all tied to demand for its power management chips in AI focused semiconductor markets. See our latest analysis for Monolithic Power Systems. The recent earnings update and dividend increase have coincided with strong momentum, with a 7 day share price return of 17.73% and a 1 year total shareholder return of 143.34%, suggesting investors are reassessing growth...

Share repurchase program and recent earnings momentum NMI Holdings (NMIH) recently announced a US$250 million share repurchase program running through December 2027, following several quarters of earnings results that exceeded expectations. This combination is drawing fresh attention from mortgage insurance investors. See our latest analysis for NMI Holdings. At a share price of US$37.91, NMI Holdings has seen short-term share price pressure, with a 90-day return of a 6.09% decline. However,...

If you are wondering whether Uniti Group's current share price reflects its underlying value, the recent performance gives you plenty to think about. The stock last closed at US$10.30, with returns of 27.2% over the past week, 28.0% over the past month, 50.8% year to date, 41.1% over one year, 132.0% over three years and a 19.9% decline over five years. Recent news coverage has focused on Uniti Group as investors reassess telecom infrastructure plays and their role in income and growth...

If you are wondering whether Comfort Systems USA at US$1,434.09 still offers value after a strong run, the key is understanding what the current price actually builds in. The stock has posted returns of 12.6% over the last week, 12.1% over the last month, 42.9% year to date, 360.8% over the last year and a very large gain over five years that is around 18x. These moves have kept Comfort Systems USA on many investors' radar, as the price action suggests shifting expectations around the...

Neurocrine Biosciences, ticker NasdaqGS:NBIX, held an official M&A call regarding Soleno Therapeutics. The call focused on a potential transaction involving Soleno Therapeutics and its assets. This development highlights a possible shift in Neurocrine’s business plans and portfolio priorities. The M&A discussion represents a material event for current and prospective shareholders of NasdaqGS:NBIX. Neurocrine Biosciences focuses on treatments for neurological and endocrine related disorders,...

Setting the scene for Church & Dwight (CHD) Church & Dwight (CHD) has drawn fresh attention after recent trading, with the share price at US$93.13 and mixed returns over the past year. This has prompted investors to reassess this household and personal care name. See our latest analysis for Church & Dwight. Recent trading reflects a mixed picture, with a 12.69% year to date share price return but a 1 year total shareholder return of an 8% decline, suggesting near term momentum is firming...

Federal Realty Investment Trust extended its dividend growth streak to 58 consecutive years, keeping its place as the only REIT on the Dividend Kings list. The company continues to recycle capital by redeveloping higher potential properties and selling more mature assets. Shares of NYSE:FRT last closed at $106.78, with the stock up 2.2% over the past week and 29.0% over the past year. For investors watching income reliability, Federal Realty Investment Trust stands out, with a 58 year...

Event driven move in California Resources shares California Resources (CRC) shares came under pressure after comments from U.S. and Iranian leaders pointed to possible de escalation of military tensions, easing the geopolitical risk premium that had been supporting oil prices and energy names. See our latest analysis for California Resources. At around US$67.71, the share price has held onto strong upward momentum, with a 30 day share price return of 4.6% and a 90 day share price return of...